此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

The Feasibility of a Virtual/Home-based OA Treatment Program in Older Adults With OA and Multimorbidity

2026年11月2日 更新者:Lindsey.A.MacFarlane、Dartmouth-Hitchcock Medical Center

Knee Osteoarthritis is one of the most common causes of chronic joint pain. Although clinical guidelines recommend weight loss and regular physical activity as first line treatments this can be difficult for patients to do. This study aims to better understand what makes it harder or easier for patients to participate in weight management or exercise programs and to design a weight and exercise program specifically tailored to older adults managing chronic health issues.

Based on input from patients and providers we will design and pilot a virtual exercise and weight management program to help patients with knee osteoarthritis in their home. Participants will be asked to fill out questionnaires about their knee pain and have phone or video check-ins with the study team to monitor progress.

研究概览

研究类型

介入性

注册 (估计的)

50

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

    • New Hampshire
      • Lebanon、New Hampshire、美国、03756

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

65年 及以上 (年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Clinician-diagnosed osteoarthritis of the knee
  • Obesity (BMI >30)
  • Cardiovascular disease and/or diabetes mellitus
  • English speaking

Exclusion Criteria:

  • Inflammatory arthritis
  • Antecedent acute trauma
  • Consistent use of a wheelchair
  • Moderate to severe dementia

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Home-based exercise and weight management program

The foundation of the program will be based on current activity as well as weight guidelines and recommendations; adjustments will be made to maximize facilitators and minimize barriers identified in previous studies.

This is the only intervention that will be assigned to participants. Program will be based on participant's current activity level and current weight guidelines.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Knee Injury and Osteoarthritis Outcomes Score (KOOS)
大体时间:3 and 6 months

A valid, reliable, and responsive scale developed for use in studies of knee problems including osteoarthritis.

3 and 6 months
Prospective preference assessment
大体时间:Baseline

Descriptive feasibility outcome, a 5 point likert scale used to determine patient willingness to participate in the research.

Baseline

次要结果测量

结果测量
措施说明
大体时间
Use, dose, and frequency of analgesics
大体时间:3 and 6 months

Patient-reported counts of the use, dose, and frequency of pain medications used, including non-steroidal anti-inflammatory drugs

3 and 6 months
Self-reported current weight
大体时间:3 and 6 months

Patients will be asked to self report their current weight at the defined time points

3 and 6 months
Participant satisfaction and adherence
大体时间:3 and 6 months

Patient satisfaction will be measured using a 5 point Likert scale for a series of questions aimed at perceived effectiveness of the intervention, ease of use and likeliness of continuing in the intervention

3 and 6 months
The Physical Activity Scale for the Elderly (PASE)
大体时间:3 and 6 months

A recommended and reliable assessment for physical activity in older adults that has demonstrated positive correlation with Actigraph monitor data

3 and 6 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2027年5月1日

初级完成 (估计的)

2027年11月1日

研究完成 (估计的)

2029年1月1日

研究注册日期

首次提交

2026年11月2日

首先提交符合 QC 标准的

2026年11月2日

首次发布 (实际的)

2026年11月6日

研究记录更新

最后更新发布 (实际的)

2026年11月6日

上次提交的符合 QC 标准的更新

2026年11月2日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

其他研究编号

  • STUDY02003585
  • 1P20GM161873-01 (美国 NIH 拨款/合同)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

The phenotypic data associated with enrolled participants will be shared by depositing these data in the Open Science Framework data repository. Additional data documentation and de-identified IPD including demographics, diagnoses, and outcomes will be deposited. Resources such as study protocols and statistical analyses codes will also be made available.

IPD 共享时间框架

Outcome data will be deposited into the Open Science Framework repository as soon as possible but no later than within one year of the completion of the funded project period for the parent away or upon acceptance of the data for publication, or public disclosure of a submitted patent application, whichever is earlier. Data will remain available for a period of 5 years.

IPD 共享访问标准

Data and supporting information will be shared with investigators working in accordance to guidelines set by the data repository. Meta-analysis data and associated phenotypic data, along with data content, format, and organization will be made available to investigators through the Open Science Framework data repository.

IPD 共享支持信息类型

  • 研究方案
  • 树液
  • 国际碳纤维联合会
  • 分析代码
  • 企业社会责任

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅